Author:
Iwamoto Jun,Takeda Tsuyoshi,Sato Yoshihiro,Uzawa Mitsuyoshi
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference25 articles.
1. Shiraki M, Kushida K, Fukunaga M et al. (1999) A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. Osteoporos Int 10: 183–192
2. Kushida K, Shiraki M, Nakamura T et al. (2002) The efficacy of alendronate in reducing the risk for vertebral fracture in Japanese patients with osteoporosis: a randomized, double-blind, active-controlled, double-dummy trial. Curr Ther Res 63:9: 606–620
3. Fukunaga M, Kushida K, Kishimoto H et al. (2002) A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. Osteoporos Int 13:971–979
4. Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC (1996) Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488–501
5. Harris ST, Watts NB, Genant HK et al. (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 282:1344–1352
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献